FDAnews
www.fdanews.com/articles/72832-chromos-molecular-enters-into-agreement-with-pfizer

Chromos Molecular Enters Into Agreement With Pfizer

May 31, 2005

Chromos Molecular Systems Inc. announced that it has entered into a nonexclusive commercial license agreement with Pfizer Inc. under which Pfizer will have the right to use the ACE System to develop cell lines for research, development and manufacturing of Pfizer products. This license agreement is an expansion of the collaborative agreement announced Dec. 16, 2004, under which Chromos is using the ACE System to engineer cell lines to express a Pfizer protein. Pfizer will continue to support this on-going work. The financial details of the license agreement were not disclosed.

()a href="http://www.biospace.com/news_story.cfm?StoryID=20219620&full=1" target="_blank">BioSpace